---  
layout: startup_page  
title: "Orphagen Pharmaceuticals"  
id: "orphagen.com"  
permalink: "/orphagenpharmaceuticalsorphagen.com12092024/"  
website: "https://www.orphagen.com/"  
funding_round: "Grant"  
funding_amount: "$1.7M"  
investors: "National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)"  
about: "Orphagen Pharmaceuticals is a biotech company focused on discovering and developing small molecule ligands that modulate orphan nuclear receptors. They are currently developing OR-812, a novel oral therapeutic for inflammatory bowel disease (IBD), targeting the retinoic acid receptor alpha (RARÎ±). Their work is based on an agnostic approach, exploring proprietary lead molecules with potential in autoimmune disease and oncology."  
markets: "Biotechnology, Pharmaceuticals, Healthtech, Medical"  
hq: "San Diego, California, United States"  
founded_year: "2001"  
linkedin: "https://www.linkedin.com/company/orphagenpharmaceuticals"  
twitter: ""  
instagram: ""  
facebook: ""  
crunchbase: "https://www.crunchbase.com/organization/orphagen-pharmaceuticals"  
pitchbook: "https://pitchbook.com/profiles/company/56241-01"  

date_display: "09-Dec-2024"  
date: "2024-12-09"

# SEO Optimization  
meta_title: "Orphagen Pharmaceuticals - Grant Funding ($1.7M)"  
meta_description: "Orphagen Pharmaceuticals, Orphagen Pharmaceuticals is a biotech company focused on discovering and developing small molecule ligands that modulate orphan nuclear receptors. The..."  
meta_keywords: "Orphagen Pharmaceuticals, Biotechnology, Pharmaceuticals, Healthtech, Medical, Grant funding"  
canonical_url: "https://startup.projectstartups.com/orphagenpharmaceuticalsorphagen.com12092024/"  
---